Skip to main navigation Skip to search Skip to main content

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis

  • Elliott M. Antman
  • , Stephen D. Wiviott
  • , Sabina A. Murphy
  • , Juri Voitk
  • , Yonathan Hasin
  • , Petr Widimsky
  • , Harish Chandna
  • , William Macias
  • , Carolyn H. McCabe
  • , Eugene Braunwald
  • Brigham and Women’s Hospital
  • North Estonian Regional Hospital
  • The Kittner and Davidai Institute of Cardiology Center
  • Charles University
  • Detar Hospital
  • Eli Lilly

Research output: Contribution to journal › Article › peer-review

333 Scopus citations

Fingerprint

Dive into the research topics of 'Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science